Vascular Embolization Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 1.94 Billion |
| Market Size (2029) | USD 2.75 Billion |
| CAGR (2024 - 2029) | 7.26 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Vascular Embolization Market Analysis
The Global Vascular Embolization Market size is estimated at USD 1.94 billion in 2024, and is expected to reach USD 2.75 billion by 2029, growing at a CAGR of 7.26% during the forecast period (2024-2029).
The outbreak of COVID-19 impacted the vascular embolization market, as hospitals and healthcare services for non-COVID indications were significantly reduced due to social distancing measures enforced globally. However, many research studies have proven that vascular embolization techniques are safe during the COVID-19 pandemic if performed with utmost care and precautions. According to a research study titled "Bronchial Artery Embolization Performed in COVID-19 Patients: Tolerance and Outcomes", published in 2020, the results demonstrated that management of severe hemoptysis (SH) in COVID-19 patients with bronchial artery embolization (BAE) was feasible and efficient, and concerning the safety guidelines, it is of utmost importance to protect the interventional radiology (IR) staff. Thus, owing to the aforementioned factors, the studied market is expected to be impacted during the COVID-19 pandemic.
The increasing prevalence of vascular diseases, technological advancements in embolization products and procedures, increasing research and development activities, and growing demand for minimally invasive procedures are the key driving factors in the global vascular embolization market. According to the 2020 updates of the World Health Organization, ischemic heart disease is responsible for 16% of the world's total deaths annually. Additionally, according to the World Health Organization, an estimated 17.9 million people die due to cardiovascular diseases worldwide, each year. This represents 35% of global deaths. Additionally, 85% of these cardiovascular disease deaths are due to heart attack and stroke. In addition, according to the article published in Cureus Journal of Medical Science in July 2020, ischemic heart disease (IHD) is a leading cause of death worldwide. Ischemic heart disease affects around 126 million individuals (1,655 per 100,000) globally, which is approximately 1.72% of the world's population. The global prevalence of ischemic heart disease is expected to exceed 1,845 per 100,000 by the year 2030.owing to cardiovascular diseases that include coronary heart disease, rheumatic heart disease, cerebrovascular disease, and other heart conditions. It is one of the leading causes of death worldwide.
Moreover, compared to conventional surgeries, the several advantages of minimally invasive surgeries, such as reduced surgical pain, injury, scarring, hospital stay, higher accuracy, and speedy recovery time, are encouraging an increasing number of patients to opt for minimally invasive balloon angioplasty surgeries. As per the data reported by the American College of Cardiology, in 2020, approximately 1.2 million angioplasties were performed in a year in the United States. Moreover, the high accessibility and affordability of hospitals, as compared to the specialty clinics, are expected to attract a large patient population.
Also, a few of the key players are developing and launching novel products and technologies to compete with the existing products, while others are acquiring and partnering with the other companies trending in the market. For instance, in February 2020, EmboCube and Torpedo devices of Merit Medical Systems Inc. were FDA indicated for the embolization of blood vessels to occlude blood flow, thus aiding in the control of bleeding and hemorrhaging in the peripheral vasculature. Thus, owing to the aforementioned factors, the studied segment is expected to grow over the forecast period. However, the high cost associated with the procedures, stringent regulations, and complications associated with these procedures are expected to hinder the growth of the market studied.
Vascular Embolization Market Trends
This section covers the major market trends shaping the Vascular Embolization Market according to our research experts:
The Non-coiling Devices Segment is Expected to Hold a Major Market Share in the Vascular Embolization Market over the Forecast Period
Factors such as the growing burden of chronic diseases and the expanding target patient pool are expected to propel the segment's growth. According to the World Health Organization report 2020, the mortality rate has been growing due to the number of chronic diseases increasing over the past 20 years, with heart disease being the leading cause of death worldwide. Since 2000, the number of deaths from heart disease has increased by nearly 2 million, to nearly 9 million in 2019. In the United States, heart disease now accounts for 16% of all deaths. This indicates a potential market demand for vascular embolization. Owing to the increasing burden of various types of chronic disorders, the market studied is expected to grow in the future.
Additionally, market players are focusing on the launch of new products in the market. For instance, in March 2021, Shape Memory Medical received approval from Japan's Pharmaceutical and Medical Devices Agency for IMPEDE-FX Embolization Plug. Impede embolization plugs are indicated to obstruct or reduce the rate of blood flow in the peripheral vasculature. Thus, owing to these factors, the non-coiling devices segment is expected to experience lucrative growth during the forecast period.
North America Holds a Significant Share in the Studied Market and Expected to do Same during the Forecast Period
North America is expected to hold a major market share in the global vascular embolization market due to the increasing prevalence of cancer and vascular-related diseases and increasing research and development activities in this region. According to the American Cancer Society estimates, in 2020, there were approximately 89,500 cancer cases diagnosed and about 9,270 cancer deaths among adolescents and young adults (AYAs) aged between 15 and 39 years in the United States. Embolization is one of the most accepted modalities of cancer treatment in patients with a variety of clinical scenarios. It is done to produce ischemia within the tumor, resulting in tumor necrosis. This effect may be further potentiated by the addition of a chemotherapeutic agent to the embolic material. Hence, the rising burden of cancer is giving growth to the embolization procedures in this region. Brain aneurysm is another major disorder that has affected the American population. As per 2019 Statistics by the Brain Aneurysm Foundation, an estimated 6.5 million people in the United States have an unruptured brain aneurysm, with an annual rate of rupture of approximately 8-10 per 100,000 people. In a patient with a brain aneurysm, coil embolization is one of the most common minimally-invasive procedures to treat an aneurysm by filling it with material that closes the sac and reduces the risk of bleeding. Hence, the increasing burden of diseases in the country is expected to drive the demand for vascular embolization.
Moreover, the North American region is ahead in technology and R&D activities in comparison to other regions, which is expected to positively impact the market. For instance, in March 2021, Instylla Inc. reported the enrollment of the first patients in the pivotal Embrace Hydrogel Embolic System (HES) global randomized clinical trial for the treatment of hypervascular tumors.
Thus, owing to the aforementioned factors, the studied market is expected to witness significant growth in North America over the forecast period.
Vascular Embolization Industry Overview
The vascular embolization market is highly competitive and consists of several major players. Some of the companies that are currently dominating the market are Medtronic PLC, Cook Medical, Stryker Corporation, Boston Scientific Corporation, Abbott Laboratories, Johnson and Johnson (CERENOVUS), Merit Medical Systems Inc., Penumbra Inc., Terumo Corporation, and Shape Memory Medical Inc. The major players have used various strategies such as expansions, new product launches, and acquisitions to increase their footprints in this market. For instance, in October 2020, Johnson and Johnson launched NIMBUS to remove tough clots and enable revascularization for patients with acute ischaemic stroke in Europe.
Vascular Embolization Market Leaders
-
Medtronic Plc
-
Cook Medical
-
Stryker Corporation
-
Boston Scientific Corporation
-
Abbott Laboratories
*Disclaimer: Major Players sorted in no particular order
Vascular Embolization Market News
- In July 2021, Terumo Medical Corporation (TMC) has the introduction of its AZUR Vascular Plug, the first and only plug compatible with a microcatheter to occlude arteries up to 8mm in diameter. The newest addition to Terumo's robust embolization portfolio is indicated for use to reduce or block the rate of blood flow in arteries of the peripheral vasculature.
- In April 2021, the US Food and Drug Administration (FDA) approved the Pipeline Flex Embolization Device with Shield Technology of Medtronic PLC, which was indicated primarily for brain aneurysms. Shield Technology enhances the flow diverter device by decreasing thrombogenicity caused due to the material.
Vascular Embolization Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Vascular Diseases
4.2.2 Technological Advancements in Embolization Products and Procedures
4.2.3 Increasing Research and Development Activities
4.3 Market Restraints
4.3.1 High Costs Associated with Embolization Procedures
4.3.2 Stringent Regulatory Norms
4.3.3 Complications Associated with Embolization Procedures
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Embolization Technique
5.1.1 Coiling Devices
5.1.2 Non-coiling Devices
5.2 By Application
5.2.1 Peripheral Vascular Disease
5.2.2 Oncology
5.2.3 Neurology
5.2.4 Urology
5.2.5 Other Applications
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Medtronic PLC
6.1.2 Cook Medical
6.1.3 Stryker Corporation
6.1.4 Boston Scientific Corporation
6.1.5 Abbott Laboratories
6.1.6 Johnson and Johnson (CERENOVUS)
6.1.7 Merit Medical Systems Inc.
6.1.8 Penumbra Inc
6.1.9 Terumo Corp
6.1.10 Shape Memory Medical Inc.
6.1.11 B. Braun Melsungen AG
6.1.12 W. L. Gore & Associates Inc.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Vascular Embolization Industry Segmentation
As per the scope of the report, vascular embolization is a procedure in which an embolic agent is injected into blood vessels to close them and stop the blood flow to a targeted area. The vascular embolization market is segmented by embolization technique, application, and geography. By embolization technique, the market is segmented into coiling devices and non-coiling devices. By application, the market is segmented into peripheral vascular disease, oncology, neurology, urology, and other applications. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Embolization Technique | |
| Coiling Devices | |
| Non-coiling Devices |
| By Application | |
| Peripheral Vascular Disease | |
| Oncology | |
| Neurology | |
| Urology | |
| Other Applications |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Vascular Embolization Market Research FAQs
How big is the Global Vascular Embolization Market?
The Global Vascular Embolization Market size is expected to reach USD 1.94 billion in 2024 and grow at a CAGR of 7.26% to reach USD 2.75 billion by 2029.
What is the current Global Vascular Embolization Market size?
In 2024, the Global Vascular Embolization Market size is expected to reach USD 1.94 billion.
Who are the key players in Global Vascular Embolization Market?
Medtronic Plc, Cook Medical, Stryker Corporation, Boston Scientific Corporation and Abbott Laboratories are the major companies operating in the Global Vascular Embolization Market.
Which is the fastest growing region in Global Vascular Embolization Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Vascular Embolization Market?
In 2024, the North America accounts for the largest market share in Global Vascular Embolization Market.
What years does this Global Vascular Embolization Market cover, and what was the market size in 2023?
In 2023, the Global Vascular Embolization Market size was estimated at USD 1.81 billion. The report covers the Global Vascular Embolization Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Vascular Embolization Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Vascular Embolization Industry Report
The Global Vascular Embolization Coils and Devices Market report provides a comprehensive industry overview, highlighting the significant market trends and market growth within this sector. The report segments the market by embolization technique, application, and geography, offering detailed market analysis and industry research.
The market forecast indicates a promising market outlook, driven by advancements in peripheral vascular disease, oncology, neurology, and urology applications. North America, Europe, Asia-Pacific, Middle East & Africa, and South America are the key regions covered in the report, each contributing to the overall industry size and market value.
The industry reports provide a historical overview and predict the market segmentation and market review up to the forecast period. The report also includes insights into market leaders and industry statistics, reflecting the market predictions and industry trends.
Market data and industry information are crucial for understanding the market segmentation and market value. The report serves as an essential industry analysis tool, offering a free report PDF download for deeper insights. Additionally, the report example and research companies included provide valuable industry research and market review.
In summary, this report is an invaluable resource for understanding the market forecast, market outlook, and market predictions, supported by comprehensive industry research and market data. The report encapsulates the market growth, industry sales, and industry trends, making it a critical document for stakeholders looking to navigate the Global Vascular Embolization Coils and Devices Market.
